...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Invites Collaborations for use of Apabetalone in Trials and Studies to Combat the Spread of COVID-19 Based on New Research
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....

posted on Mar 23, 2020 02:28PM
Log in to use the IP Check tool [?]

CCD - As far as I am aware apabetalone is the first and only BRD2 selective drug to be tested in humans in a PIII Trial, BETonMACE.

I would be surprised if the results of BETonMACE presented on Oct 16 2020 haven't been reviewed at least 50 times this morning.

tada

4 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply